Cellbag Bioreactor Chambers Market Segmentation by Material (Ethylene Vinyl Acetate Copolymer, Low Density Polyethylene, Thermoplastic Elastomer, Polyester); by Component (Bioclear Films, Barbed Ports, MCP Connectors); by Application (Antibody Production, Virus Production); by Scale (<50L, 50-100L, and >100L); by End-User (Pharmaceutical, Biopharmaceutical, Drug Discovery Companies, and Research Institutes)-Global Demand Analysis & Opportunity Outlook 2020-2030

  • Product Code:
    RP-ID-10352283
  • Published Date:
    24 Jan 2022
  • Region:
    Global
  • Pages:
    208
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-54

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The Research Report is Updated with 2021 Base Year, 2022 Estimated year and Forecast till 2031 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2021 as base year, 2022 as estimated year and forecast to 2031. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Global Cellbag Bioreactor Chambers Market Highlights Over 2020 - 2030

The global cellbag bioreactor chambers market is estimated to garner a revenue of USD 5124.6 Million by the end of 2030 by growing at a CAGR of 12.7% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2020, the market registered a revenue of USD 1554.0 Million. The growth of the market can primarily be attributed to the growing research in the field of healthcare and the rising trends of cell culture in the field of cellular and molecular biology. Cell culture is an emerging field of biological science and has recently gained significant attention of the researchers, backed by the increasing number of research projects carried out in this area. With the increasing number of research projects related to cell culture, the demand for cellbag bioreactor chambers is also projected to increase, and in turn, drive the market growth in the coming years.

 

Cellbag Bioreactor Chambers Market Graph

 

CLICK TO DOWNLOAD SAMPLE REPORT

 

One of the major factors that is driving the attention of researchers in the field of molecular biology is the growing prevalence of chronic diseases, especially cancer. According to the statistics by the World Health Organization (WHO), the most common causes of cancer in the year 2020 was breast, lung, colon & rectum cancers, followed by prostate, skin (non-melanoma), and stomach cancers with 2.26 Million cases, 2.21 Million cases, 1.93 Million cases, 1.41 Million cases, 1.20 Million cases, and 1.09 Million cases respectively. Cell culture is an important process used in the process of replacing cancer cells. Growing awareness for stem cell therapies worldwide, and the rising adoption of this therapy for treating spinal cord injuries, Parkinson’s disease, diabetes, Alzheimer’s disease, and stroke among others, are also expected to create numerous opportunities for market growth. Moreover, increasing cell-based research along with the growing technological advancements in the field of devising advanced medical and healthcare devices, including bioreactors, are also expected to accelerate the market growth in the coming years.

Global Cellbag Bioreactor Chambers Market Regional Synopsis

Regionally, the global cellbag bioreactor chambers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to garner the largest revenue of USD 2269.2 Million by the end of 2030, up from a revenue of USD 723.1 Million in the year 2020. The growth of the market in the region can primarily be attributed to the growing prevalence of chronic diseases in the region, primarily in the United States, along with the elevating count of oncology-related cell therapy clinical trials registered in the region. According to the statistics by the Centers for Disease Control and Prevention (CDC), out of 10 adults, 6 adults in the United States have a chronic disease. The market in Europe, on the other hand, is projected to garner the second-largest revenue of USD 1258.9 Million by the end of 2030, up from a revenue of USD 376.1 Million in the year 2020. The market in the region is further segmented by country into Germany, United Kingdom, France, Italy, Spain, Russia, Netherland, and the Rest of Europe. Out of these, the market in Germany is anticipated to gain the largest revenue of USD 240.8 Million by the end of 2030, up from a revenue of USD 68.8 Million in the year 2020.

Growth Drivers and Challenges Impacting the Growth of the Global Cellbag Bioreactor Chambers Market

Growth Drivers

  • Growing Technological Advancements in the Field of Medical and Healthcare Devices

  • Rising Cell-Based Research and Development Activities

Challenges

  • High Cost of the Equipment

  • Regulatory Concerns with the Use of Bioreactors

Global Cellbag Bioreactor Chambers Market Segmentation Synopsis

The global cellbag bioreactor chambers market is segmented by material into ethylene vinyl acetate copolymer, low density polyethylene, thermoplastic elastomer, polyester, polypropylene, and others. Out of these, the polypropylene segment is anticipated to garner the largest revenue of USD 1265.8 Million by the end of 2030, up from a revenue of USD 372.0 Million in the year 2020. By component, the market is segmented into bioclear films, barbed ports, MCP connectors, silicone tubing, internal perfusion filters, tubing adaptors, and others. Out of these, the tubing adaptors segment is projected to display the second-largest revenue of USD 786.8 Million by the end of 2030, up from a revenue of USD 223.6 Million in the year 2020. By application, the market is segmented into antibody production, virus production, insect cell production, vaccines, CGMP production, and others. Out of these, the vaccines segment is anticipated to garner the second-largest revenue of USD 1284.7 Million by the end of 2030, up from a revenue of USD 376.8 Million in the year 2020. By scale, the market is segmented into <50L, 50-100L, and >100L. Out of these, the <50L segment is projected to display the largest revenue of USD 2857.4 Million by the end of 2030. Moreover, by end-user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, drug discovery companies, and research institutes. Out of these, the biopharmaceutical companies segment is anticipated to garner the largest revenue of USD 1730.0 Million by the end of 2030.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global cellbag bioreactor chambers market that are included in our report are Thermo Fisher Scientific, Avantor, Inc., Global Life Sciences Solutions USA LLC (Cytiva), Sartorius AG, Pall Corporation, Celltainer Biotech BV, Adolf Kuhner AG, Merck KGaA, TERUMO BCT, INC., and others.

Latest Developments in the Global Cellbag Bioreactor Chambers Market:

  • October 21st, 2021: TERUMO BCT, INC. announced that it has opened its manufacturing facility in Costa Rica that is aimed at producing medical devices that collect and separate blood and cells for use in cell collection and processing organizations, hospitals, and therapeutic apheresis clinics among others. The new 20,000 square meter plant has been built with an investment amount of USD 60 Million.

  • July 26th, 2017: Pall Corporation announced that it has introduced the mPath bioreactor control system that is aimed at delivering accurate measurement and control of single-use process development-scale bioprocesses.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.

  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.

  • The report includes detailed company profiles of the major players dominating the market.

  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.

  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

 1.      Introduction

1.1.  Market Definition

1.2.Market Segmentation

2.    Assumptions

3.    Research Methodology

3.1.Research Process

3.2.                    Primary Research

3.3.                    Secondary Research

4.    Executive Summary – Global Cell Therapy Technologies Market

5.     Market Dynamics

5.1. Market Drivers

5.2.                     Market Trends

6.    Key Market Opportunities

7.     Major Roadblocks for the Market Growth

8.    Regulatory and Standards Landscape

9.    Industry Risk Analysis

10.            Pricing Analysis of Cell therapy Technologies Market

11.  Value Chain Analysis

12.Impact of COVID-19 on the Cell Therapy Technologies Market

13.Market Share Analysis Based on Therapy

14.Competitive Positioning

15. Competitive Landscape

15.1.                  Market Share Analysis, 2020

15.2.                 Competitive Benchmarking

15.3.                 Company Profiles

15.3.1.                      Lonza Group Ltd.

15.3.2.                     Sartorius AG

15.3.3.                     Danaher Corporation

15.3.4.                     Becton

15.3.5.                     Dickinson and Company

15.3.6.                     Thermo Fisher Scientific Inc.

15.3.7.                     Avantor, Inc.

15.3.8.                     Eppendorf SE

15.3.9.                     Miltenyi Biotec B.V. & Co. KG

16.KOL Mapping

17. Bioreactors Market Analysis w.r.t. Product, Region, and Year

18.Future Forecast of the Manufactures and Startup Companies

19.Global Cell Therapy Technologies Market 2020-2030

19.1.                  Market Overview

19.2.                By Value (USD Million)

20.          Global Cell Therapy Technologies Market-Segmentation analysis 2020-2030

20.1.                Product

20.1.1.                     Consumables, 2020-2030F (USD Million)

20.1.2.                    System & Software, 2020-2030F (USD Million)

20.1.3.                    Equipment, 2020-2030F (USD Million)

20.1.3.1. Cell Processing Equipment, 2020-2030F (USD Million)

20.1.3.2.                        Single-Use Equipment, 2020-2030F (USD Million)

20.1.3.3.                        Other Cell Therapy Equipment, 2020-2030F (USD Million)

20.2.              Process

20.2.1.                    Process Monitoring and Quality Control, 2020-2030F (USD Million)

20.2.2.                  Cell Processing, 2020-2030F (USD Million)

20.2.3.                  Cell Preservation, distribution and Handling, 2020-2030F (USD Million)

20.3.              Cell Type

20.3.1.                    T-Cells, 2020-2030F (USD Million)

20.3.2.                  Stem Cells, 2020-2030F (USD Million)

20.3.3.                  Other Cells, 2020-2030F (USD Million)

20.4.              End-User

20.4.1.                    Contract Research Organizations (CROs), 2020-2030F (USD Million)

20.4.2.                  Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)

20.4.3.                  Cell banks, 2020-2030F (USD Million)

20.4.4.                  Research institutes, 2020-2030F (USD Million)

20.4.5.                   Other End-Users, 2020-2030F (USD Million)

20.5.               Region

20.5.1.                    North America, 2020-2030F (USD Million)

20.5.2.                   Europe, 2020-2030F (USD Million)

20.5.3.                   Asia Pacific, 2020-2030F (USD Million)

20.5.4.                   Latin America, 2020-2030F (USD Million)

20.5.5.                   Middle East & Africa, 2020-2030F (USD Million)

21.North America Therapy Technologies Market-Segmentation analysis 2020-2030

21.1.                  Product

21.1.1.                       Consumables, 2020-2030F (USD Million)

21.1.2.                      System & Software, 2020-2030F (USD Million)

21.1.3.                      Equipment, 2020-2030F (USD Million)

21.1.3.1.   Cell Processing Equipment, 2020-2030F (USD Million)

21.1.3.2.  Single-Use Equipment, 2020-2030F (USD Million)

21.1.3.3.  Other Cell Therapy Equipment, 2020-2030F (USD Million)

21.2.                Process

21.2.1.                      Process Monitoring and Quality Control, 2020-2030F (USD Million)

21.2.2.                    Cell Processing, 2020-2030F (USD Million)

21.2.3.                    Cell Preservation, distribution and Handling, 2020-2030F (USD Million)

21.3.                Cell Type

21.3.1.                      T-Cells, 2020-2030F (USD Million)

21.3.2.                    Stem Cells, 2020-2030F (USD Million)

21.3.3.                    Other Cells, 2020-2030F (USD Million)

21.4.                End-User

21.4.1.                      Contract Research Organizations (CROs), 2020-2030F (USD Million)

21.4.2.                    Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)

21.4.3.                    Cell banks, 2020-2030F (USD Million)

21.4.4.                    Research institutes, 2020-2030F (USD Million)

21.4.5.                     Other End-Users, 2020-2030F (USD Million)

21.5.                 Country

21.5.1.                      United States, 2020-2030F (USD Million)

21.5.2.                     Canada, 2020-2030F (USD Million)

22.           Europe Therapy Technologies Market-Segmentation analysis 2020-2030

22.1.                Product

22.2.               Process

22.3.               Cell-Type

22.4.               End-User

22.5.               Country

22.5.1.                     Germany

22.5.2.                   United Kingdom

22.5.3.                   France

22.5.4.                   Italy

22.5.5.                    Spain

22.5.6.                   Russia

22.5.7.                    Netherland

22.5.8.                   Rest of Europe

23.           Asia Pacific Technologies Market-Segmentation analysis 2020-2030

23.1.                Product

23.2.               Process

23.3.               Cell-Type

23.4.               End-User

23.5.               Country

23.5.1.                     China

23.5.2.                   India

23.5.3.                   Japan

23.5.4.                   South Korea

23.5.5.                    Australia

23.5.6.                   Singapore

23.5.7.                    Rest of APAC

24.           Latin America Technologies Market-Segmentation analysis 2020-2030

24.1.                Product

24.2.               Process

24.3.               Cell-Type

24.4.               End-User

24.5.               Country

24.5.1.                     Brazil

24.5.2.                   Argentina

24.5.3.                   Mexico

24.5.4.                   Rest of LATAM

25.           Middle East & Africa Technologies Market-Segmentation analysis 2020-2030

25.1.                 Product

25.2.               Process

25.3.               Cell-Type

25.4.               End-User

25.5.                Country

25.5.1.                     GCC

25.5.2.                    Israel

25.5.3.                    South Africa

25.5.4.                    Rest of MEA

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
  1. Thermo Fisher Scientific
  2. Avantor, Inc.
  3. Global Life Sciences Solutions USA LLC (Cytiva)
  4. Sartorius AG
  5. Pall Corporation
  6. Celltainer Biotech BV
  7. Adolf Kuhner AG
  8. Merck KGaA
  9. TERUMO BCT, INC.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports